Summary: Donation of CCP, Blood Components and HCT/Ps, Including Information on COVID-19 Vaccines or Treatment with CCP or Monoclonals (updated 04/14/21)
This section contains information on questionnaires used to screen prospective donors and help ensure the safety of the donation process as well as the product being donated. AABB has played a leadership role in the development of model questionnaires for blood collection facilities as well as for facilities involved in the collection of hematopoietic progenitor cells (HPCs).
Australia to Expand Individual Donor Assessment to Blood Donation in April
February 03, 2026
Switzerland to Remove Donor Deferrals Related to vCJD Risk
January 14, 2026
AABB Members Receive Complimentary Access to 2 Annual Meeting RISE Sessions
December 02, 2025
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
